Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary objective:
The primary objective of this trial is:
- To evaluate the efficacy of initiating Lantus in combination with oral antidiabetics
drugs compared to oral antidiabetic treatment optimised by enhancing hygienic and
dietary measures in type 2 diabetics whose blood glucose control is acceptable but not
optimal on maximum oral treatment, based on the number of patients achieving a HbA1c
value < 7% at the end of treatment.
Secondary objectives:
The secondary objectives of this trial are to compare between the two treatment groups:
- The variation in HbA1c between baseline and end of trial.
- The frequency of episodes of symptomatic hypoglycaemia (diurnal and nocturnal), severe
hypoglycaemia (diurnal and nocturnal) and asymptomatic hypoglycaemia.
- Mean blood glucose levels at different times of the day.
- The variation in weight and lipid in each group between baseline and end of trial.
- The incidence of adverse events.